Agenerase

Active Ingredient(s): Amprenavir
FDA Approved: * April 15, 1999
Pharm Company: * GLAXOSMITHKLINE
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Agenerase Overview

Amprenavir (original brand name Agenerase, GlaxoSmithKline) is a protease inhibitor used to treat HIV infection. It was approved by the Food and Drug Administration on April 15, 1999, for twice-a-day dosing instead of needing to be taken every eight hours. The convenient dosing came at a price, as the dose required is 1,200mg, delivered in 8 (eight) very large 150 mg gel capsules or 24 (twenty-four) 50 mg gel capsules twice daily.[1] It was patented in 1992 and approved for me...

Read more Agenerase Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Amprenavir

Recent Agenerase Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Amprenavir or a similar ingredient: (3 results)

• AMPRENAVIR
• FOSAMPRENAVIR
• LEXIVA Fosamprenavir